J P Grunfeld
Overview
Explore the profile of J P Grunfeld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
262
Citations
1781
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zannad F, Kessler M, Lehert P, Grunfeld J, Thuilliez C, Leizorovicz A, et al.
Kidney Int
. 2006 Jul;
70(7):1318-24.
PMID: 16871247
Cardiovascular events (CVEs) are the leading cause of death in chronic hemodialysis patients. Results of trials in non-end-stage renal disease (ESRD) patients cannot be extrapolated to patients with ESRD. It...
2.
3.
Boutouyrie P, Laurent S, Laloux B, Lidove O, Grunfeld J, Germain D
Acta Paediatr Suppl
. 2003 Feb;
91(439):62-6.
PMID: 12572845
Aim: The enzymatic defect in Fabry disease results in the slow systemic deposition of uncleaved glycosphingolipids in the lysosomes of vascular endothelium and smooth muscle cells, leading to ischaemic strokes,...
4.
Grunfeld J
Bull Mem Acad R Med Belg
. 2002 Oct;
156(10-12):491-6; discussion 496-7.
PMID: 12371269
Clinical genetics has reached a crossroads. Indeed recent progress in molecular genetics has generated great hope. This progress has consequences beyond genetic diseases, leading to the understanding of much more...
5.
Presne C, Fakhouri F, Kenouch S, Stengel B, Kreis H, Grunfeld J
Presse Med
. 2002 Aug;
31(18):828-33.
PMID: 12148451
Objectives: Study the renal consequences of lithium therapy and find out whether lithium-induced chronic renal toxicity can provoke a progressive nephropathy, leading to advanced renal failure, requiring periodical dialysis. Methods:...
6.
Brenner B, Cooper M, de Zeeuw D, Grunfeld J, Keane W, Kurokawa K, et al.
J Renin Angiotensin Aldosterone Syst
. 2002 Apr;
1(4):328-35.
PMID: 11967819
The RENAAL Study is a double-blind, placebo-controlled trial to evaluate the renal protective effects of losartan in Type 2 diabetic patients with nephropathy. The study has enrolled 1513 patients and...
7.
Lidove O, Joly D, Barbey F, Bletry O, Grunfeld J
Rev Med Interne
. 2002 Jan;
22 Suppl 3:384s-392s.
PMID: 11794883
Introduction: Fabry disease is an X-linked recessive abnormality of glycosphingolipid metabolism that is due to deficiency of the lysosomal enzyme alpha-galactosidase A. Current Knowledge And Key Points: A majority of...
8.
Grunfeld J, Lidove O, Joly D, Barbey F
J Inherit Metab Dis
. 2002 Jan;
24 Suppl 2:71-4; discussion 65.
PMID: 11758682
Renal dysfunction is a major complication in hemizygous males with Fabry disease. This often results in end-stage renal failure (ESRF), requiring dialysis or transplantation, on average 10 years after the...
9.
Jungers P, Massy Z, Nguyen-Khoa T, Choukroun G, Robino C, Fakhouri F, et al.
Nephrol Dial Transplant
. 2001 Dec;
16(12):2357-64.
PMID: 11733627
Background: Late nephrological referral of chronic renal failure patients has been shown to be associated with high morbidity and short-term mortality on dialysis. However, the impact of predialysis nephrological care...
10.
Achard J, Potier J, Delahousse M, Stern N, Blanchard A, Guilbaud J, et al.
Adv Nephrol Necker Hosp
. 2001 Nov;
31:55-68.
PMID: 11692471
No abstract available.